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Introduction
Familial Mediterranean fever (FMF) is the most frequent
monogenic autoinflammatory disease (AID). Hidradenitis
suppurativa (HS) is an inflammatory skin disease charac-
terized by recurrent abscesses and scarring in apocrine
gland-bearing areas. HS shares common features with
AID including a positive correlation between the increase
of acute phase reactants (APR) and the severity of the
disease. HS can be associated with other AID.
Objectives
To describe a series of patients who had both HS and
FMF.
Patients and methods
Descriptive observational retrospective study relating the
main characteristics of patients who had HS among the
FMF cohort followed in the French adult reference center.
Results
Among 151 FMF adult patients, we identified 6 patients
with HS, 2 women, with a median age of 36 years
[range 27-70]. Median age for first symptoms of FMF
was 11.5 years [3-30], and for colchicine administration
20.5 years [4-34] with a mean dosage at the time of the
study of 1.25mg/day [1-2]. HS was diagnosed at a med-
ian age of 31.5 years [13-63]. Treatment consisted in
consecutive antibiotics (5 patients), surgery (3 patients),
and no treatment in one recent diagnosed patient.
There was no concurrence between HS and FMF flares.
APR were normal in 3 patients. For the 3 remaining
patients: one took irregularly 1mg/d of colchicine and
had no FMF flares but an active HS; the second one had
1.5mg/d of colchicine and the third patient 2mg/d, both
had active FMF and HS. For the older patient of the series,
FMF occurred at the age of 10 years and HS at 15 years;
AA amyloidosis was diagnosed when he was 69 years old
because of proteinuria and increased APR whereas he
took 1mg/d of colchicine, thus he received interleukin
(IL)-1 inhibitor in association with colchicine.
In the literature, IL-1 inhibitor demonstrated an effi-
cacy in 9 out of 12 patients with HS and no AID. Three
cases of AA amyloidosis associated with HS were
reported.
Conclusion
FMF and HS are suspected to share common pathways to
the activation of inflammasome and the secretion of IL-1
beta. The association of FMF and HS could induce a
greater and protracted secretion of IL-1 beta and enhance
the risk of earlier occurrence of AA amyloidosis. Thus,
APR should be carefully monitored in patients with FMF
and HS and treatment should be intensified if needed in
order to prevent AA amyloidosis.
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